Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04308590
Title Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas (GRADIENT)
Acronym GRADIENT
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Corcept Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ROU | POL | ITA | ISR | ESP | DEU | BGR | AUT


No variant requirements are available.